A detailed history of Keeley Teton Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Keeley Teton Advisors, LLC holds 1,955 shares of ABBV stock, worth $350,981. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,955
Previous 1,954 0.05%
Holding current value
$350,981
Previous $335,000 15.22%
% of portfolio
0.04%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $163 - $199
1 Added 0.05%
1,955 $386,000
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $154 - $180
-1 Reduced 0.05%
1,954 $335,000
Q1 2024

May 14, 2024

SELL
$159.82 - $182.1 $70,320 - $80,124
-440 Reduced 18.37%
1,955 $356,000
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $33,299 - $37,502
-242 Reduced 9.18%
2,395 $371,000
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $352,276 - $407,812
2,637 New
2,637 $393,000
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $728,142 - $906,125
-5,495 Reduced 67.57%
2,637 $355,000
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $8,531 - $9,825
-59 Reduced 0.72%
8,132 $1.3 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $52,557 - $63,030
380 Added 4.86%
8,191 $1.32 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $46,302 - $53,105
-345 Reduced 4.23%
7,811 $1.05 Million
Q1 2022

May 18, 2022

SELL
$131.98 - $163.75 $7,522 - $9,333
-57 Reduced 0.69%
8,156 $1.32 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $873,863 - $991,966
8,213 New
8,213 $886,000
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $888,708 - $990,072
-8,447 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $14,322 - $15,766
-140 Reduced 1.63%
8,447 $914,000
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $4,265 - $5,759
-53 Reduced 0.61%
8,587 $920,000
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $1,116 - $1,310
-13 Reduced 0.15%
8,640 $757,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $634,870 - $849,551
8,653 New
8,653 $850,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Keeley Teton Advisors, LLC Portfolio

Follow Keeley Teton Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keeley Teton Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keeley Teton Advisors, LLC with notifications on news.